Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2005
06/29/2005EP1545502A2 Keto cannabinoids with therapeutic indications
06/29/2005EP1545501A2 Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
06/29/2005EP1545500A1 Paclitaxel composition for the intravesical treatment of bladder tumor and preparation method thereof
06/29/2005EP1545499A1 Composition for solubilization of paclitaxel and preparation method thereof
06/29/2005EP1545498A2 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same
06/29/2005EP1545496A2 Nutritional supplement for adolescents
06/29/2005EP1545495A1 P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient
06/29/2005EP1545494A1 Use of propionyl l-carnitine for the preparation of a medicament for the treatment of glaucoma
06/29/2005EP1545493A2 Methods and compositions to treat conditions associated with neovascularization
06/29/2005EP1545492A1 Conjugated linoleic acid powder
06/29/2005EP1545491A1 Therapeutic use of fused bicyclic or tricyclic amino acids
06/29/2005EP1545490A1 Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract
06/29/2005EP1545489A1 Treatment of depression secondary to pain (dsp)
06/29/2005EP1545488A1 Choline ascorbate formulations
06/29/2005EP1545487A1 Use of a sri and vitamin b6 for the treatment of neurological and mental disorders
06/29/2005EP1545486A1 Use of bupropion for the manufacture of a medicament for treating restless legs syndrome
06/29/2005EP1545485A2 Treatment of cns disorders with trans-4- (3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine
06/29/2005EP1545484A1 Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
06/29/2005EP1545483A2 Non-nucleoside reverse transcriptase inhibitors
06/29/2005EP1545482A1 Novel nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same
06/29/2005EP1545481A1 Combination chemotherapy compositions and methods
06/29/2005EP1545480A1 Breath freshening and oral cleansing product using citral
06/29/2005EP1545479A2 Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors
06/29/2005EP1545477A1 Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
06/29/2005EP1545475A1 Enteric composition for the manufacture of soft capsule wall
06/29/2005EP1545473A2 Modified release, multiple unit drug delivery systems
06/29/2005EP1545471A1 Storage stable tablets of fosinopril sodium
06/29/2005EP1545469A1 Method to improve pharmaceutical tablets having a matrix of cellulose ether
06/29/2005EP1545468A2 Sustained-release opioid formulations and methods of use
06/29/2005EP1545467A1 Solid pharmaceutical formulations comprising telmisartan
06/29/2005EP1545461A2 Combined immediate release and extended release analgesic composition
06/29/2005EP1545458A2 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer
06/29/2005EP1545456A1 Pharmaceutical compositions containing keto-acids for endoperitoneal administration
06/29/2005EP1545454A1 Fast releasing, solid administration form for oral application of active ingredients which are hard to dissolve
06/29/2005EP1545453A1 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
06/29/2005EP1545447A2 Breath freshening and oral cleansing product using salicylaldehyde
06/29/2005EP1545432A2 Use of excipients to increase dna uptake by swine muscle cells
06/29/2005EP1545431A2 Methods of treating involuntary facial spasms and facial wrinkles
06/29/2005EP1545429A2 Methods and compositions for treatment of dermal conditions
06/29/2005EP1545412A1 Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues
06/29/2005EP1545407A2 Vaginal health products
06/29/2005EP1545287A2 Vasoregulating compounds and methods of their use
06/29/2005EP1545225A1 Organic acids incorporated edible antimicrobial films
06/29/2005EP1545218A2 Full range nutritional supplements from plant materials and methods for their manufacture
06/29/2005EP1545211A1 Nodulisporic acid derivative spot-on formulations for combating parasites
06/29/2005EP1545210A1 Stable, low free formaldehyde, synergistic antimicrobial compositions of aldehyde donors and dehydroacetic acid
06/29/2005EP1545208A2 Methods of using beta glucan as a radioprotective agent
06/29/2005EP1545206A2 Compositions and products containing enantiomeric equol, and methods for their making
06/29/2005EP1545204A2 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
06/29/2005EP1485352B1 Azaspiro compounds for the treatment of pain
06/29/2005EP1443948B1 Process for the preparation of anthocyanin-containing products
06/29/2005EP1432686B1 Tetrahydroisochinolines, their production and the use thereof as analgesics
06/29/2005EP1421093B1 Crystaline clindamycin free base
06/29/2005EP1408943B1 Pharmaceutical formulation containing an ltb4 antagonist and a wetting agent
06/29/2005EP1395550B1 Cycloalkenylsulfonamide derivatives
06/29/2005EP1347759B1 Antibacterial compounds
06/29/2005EP1343786B1 Novel pyridine-substituted pyrazolopyridine derivatives
06/29/2005EP1339408B1 Liquid drug formulations having improved oral tolerability
06/29/2005EP1339400B1 N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide deformylase for treating microbial infections
06/29/2005EP1322648B1 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents
06/29/2005EP1319651B1 2-Aminopropane-1,3-diol compound, pharmaceutical use thereof and synthetic intermediates therefor
06/29/2005EP1315727B1 7-oxo pyridopyrimidines
06/29/2005EP1315473B1 Use of ectoine or ectoine derivatives for oral care
06/29/2005EP1289576B1 Drug combinations useful for prevention of restenosis
06/29/2005EP1274701B1 [1,4']-bipiperidine compounds
06/29/2005EP1246624B1 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans
06/29/2005EP1242069B1 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
06/29/2005EP1237866B1 Amycomycin, a process for its production and its use as a pharmaceutical
06/29/2005EP1225951B1 A dual adhesive transdermal drug delivery system
06/29/2005EP1184037B1 Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance
06/29/2005EP1172115B1 Hemostatic soluble cellulose fibers containing coagulating protein for treating wound and process for producing the same
06/29/2005EP1165077B1 Viral treatment
06/29/2005EP1152762B8 Use of desoxypeganine in the treatment of alzheimer's dementia
06/29/2005EP1140114B1 Pharmaceutical formulations
06/29/2005EP1027362B1 2-halo-6-o-substituted ketolide derivatives
06/29/2005EP1025216B1 Transgenic animal models for cardiac hypertrophy and uses thereof
06/29/2005EP1021186B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha
06/29/2005EP1005861B1 Remedies for frequent urination and urinary incontinence
06/29/2005EP0909562B1 Injections containing lipid a analogues and process for the preparation thereof
06/29/2005EP0901459B1 Calcilytic compounds
06/29/2005EP0862456B1 Hyaluronidase compositions for treating intravitreal hemorrhagic blood
06/29/2005EP0850055B1 Protein tyrosine kinase inhibitors for treating osteoarthritis
06/29/2005EP0735888B1 Purine compositions
06/29/2005EP0721501B1 Pharmaceutical composition comprising phosphatase or a derivative thereof
06/29/2005CN1633498A Novel insulin/IGF/relaxin family polypeptides and dnas thereof
06/29/2005CN1633446A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
06/29/2005CN1633444A 6-11 bicyclic ketolide derivatives
06/29/2005CN1633443A Arylation method for the functionalization of O-allyl erythromycin derivatives
06/29/2005CN1633439A Processes for desolvating solvates of atorvastatin hemi-calcium and atorvastatin hemi-calcium essentially free of organic solvent
06/29/2005CN1633437A Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
06/29/2005CN1633435A Tricyclic n-acyl compounds
06/29/2005CN1633434A Imidazo[1, 2-a]pyridine derivative
06/29/2005CN1633433A N-aroyl cyclic amines
06/29/2005CN1633432A Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
06/29/2005CN1633431A 喹唑啉衍生物类激酶抑制剂 Quinazoline derivatives kinase inhibitors
06/29/2005CN1633430A Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders
06/29/2005CN1633429A 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
06/29/2005CN1633428A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
06/29/2005CN1633421A Oxazole/thiazol-derivatives activators of the hppar-alpha receptor
06/29/2005CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
1 ... 4637 4638 4639 4640 4641 4642 4643 4644 4645 4646 4647 4648 4649 4650 4651 4652 4653 4654 4655 4656 4657 ... 7860